Overview

Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.

Status:
Suspended

Trial end date:
2014-02-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to determine whether treatment of the low IGF-1 syndrome in patients with CHF is able to modify some functional parameters, recognized as valid surrogate end-points of CHF progression.

Phase:

Phase 2

Details

Lead Sponsor:

Federico II University

Treatments:

Hormones